Loading insider details...
Latest Form 4 (Jul 2, 2026): Exercise/Conversion of 2,437 EYPT shares, $20.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 2, 2026 | EyePoint, Inc. (EYPT) | Exercise/Conversion | 2,437 | $20.1K |
| Apr 20, 2026 | EyePoint, Inc. (EYPT) | Exercise/Conversion | 2,437 | $20.1K |
| Mar 5, 2026 | EyePoint, Inc. (EYPT) | Exercise/Conversion | 2,438 | $20.1K |
| Feb 18, 2026 | EyePoint, Inc. (EYPT) | Exercise/Conversion | 2,437 | $20.1K |
| Jan 7, 2026 | EyePoint, Inc. (EYPT) | Exercise/Conversion | 29,250 | $241.6K |
| Jan 6, 2026 | EyePoint, Inc. (EYPT) | Exercise/Conversion | 19,667 | n/a |
| Nov 12, 2025 | EyePoint Pharmaceuticals, Inc. (EYPT) | Sale | 2,722 | $31.6K |
| Jan 7, 2025 | EyePoint Pharmaceuticals, Inc. (EYPT) | Grant/Award | 59,000 | n/a |
| Mar 4, 2024 | EyePoint Pharmaceuticals, Inc. (EYPT) | Grant/Award | 125,000 | n/a |